VIENNALAB - Established innovations in diagnostics

The BRAF gene is mutated in approximately 8% of human tumors, mostly melanoma, colorectal and thyroid cancers. The BRAF StripAssays® rapidly identify the most relevant mutations in the BRAF gene.

BRAF Mutations

  • BRAF encodes a serine/threonine protein kinase which plays a role in signalling pathways involved in cell proliferation and differentiation.
  • Some BRAF mutations significantly increase the BRAF gene product leading to neoplastic growth.
  • Identification of BRAF genetic variants is thus the key to the best therapy for melanoma, colorectal and thyroid cancer.

Product Details

BRAF 600/601 StripAssay® ref5-560
BRAF StripAssay® ref5-570
KRAS-BRAF StripAssay® ref5-580